Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature

OBJECTIVE: It is reported that adding cabergoline to somatostatin analog (SSA) normalizes IGF-1 levels approximately in one-third of patients with acromegaly. We investigated the effect of combination therapy and potential predictors of response in patients with acromegaly who do not respond to SSA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kizilgul, Muhammed, Duger, Hakan, Nasiroglu, Narin Imga, Sencar, Erkam, Hepsen, Sema, Akhanli, Pinar, Berker, Dilek, Cakal, Erman, Bostan, Hayri, Ucan, Bekir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832853/
https://www.ncbi.nlm.nih.gov/pubmed/35612842
http://dx.doi.org/10.20945/2359-3997000000481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832853/
https://www.ncbi.nlm.nih.gov/pubmed/35612842
http://dx.doi.org/10.20945/2359-3997000000481

Ejemplares similares